MiMedx Wants to Draw More Institutional Investors After Cleaning Up Its Accounting
wsj.com
news
2022-06-02 11:30:00

Biotechnology company MiMedx Group Inc. is looking to attract more long-term institutional investors to boost its sagging stock price and market value following an accounting investigation.The Marietta, Ga.-based company, which makes skin grafts and biologic implants to treat wounds, plans to double the percentage of institutional shareholders in the coming years from about 32% as of March 31, Chief Financial Officer Pete Carlson said. With individual investors holding about 46% of the company's stock, the remaining 22% is owned by insiders and holders of preferred stock, which can be converted into common shares.
